Loading…
Organogenesis Holdings Inc. is projected to rise to $2.56 by 2027, a +8% move from its current price of $2.37. ORGO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $2.30 | $2.37 | $2.44 | +0.05% |
| Aug 4 | $2.27 | $2.37 | $2.47 | +0.10% |
| Aug 5 | $2.25 | $2.37 | $2.50 | +0.14% |
| Aug 6 | $2.24 | $2.37 | $2.52 | +0.19% |
| Aug 7 | $2.22 | $2.38 | $2.54 | +0.24% |
| Aug 8 | $2.21 | $2.38 | $2.56 | +0.29% |
| Aug 9 | $2.20 | $2.38 | $2.57 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.20 | $2.38 | $2.57 | +0.34% |
| Week 2 | $2.13 | $2.39 | $2.67 | +0.68% |
| Week 3 | $2.09 | $2.39 | $2.75 | +1.01% |
| Week 4 | $2.05 | $2.40 | $2.81 | +1.35% |
| Week 5 | $2.02 | $2.41 | $2.88 | +1.70% |
| Week 6 | $1.99 | $2.42 | $2.94 | +2.04% |
| Week 7 | $1.97 | $2.43 | $2.99 | +2.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Organogenesis Holdings Inc. is a regenerative medicine company that develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
Its portfolio includes Affinity and Novachor, amnion and chorion placental allografts for chronic and acute wounds; Apligraf, a bioengineered bi-layered skin substitute for venous leg ulcers and diabetic foot ulcers; Dermagraft, NuShield, PuraPly AM and SX, PuraPly MZ, PuraForce, FortiShield, TransCyte, ReNu, and other placental tissue grafts used to support native healing.
Organogenesis is headquartered in Canton, Massachusetts.
ORGO is currently priced at $2.47 per share and has a market capitalization of $317.83M.
Its rank is 3296.
The near-term picture is neutral, with a longer-run outlook suggesting upside potential based on the year-by-year forecast.
The forecast includes 2026 through 2050 projections, highlighting progressive gains: 2026 avg $2.47, 2030 avg $3.29, and 2050 avg $13.82, with max values reaching $4.95 (2030) and $27.20 (2050).
A major floor 14.3% below — a decisive break under it would weaken the trend.
The nearest floor, 4.2% below — buyers have tended to step in here.
The nearest ceiling, 13.1% above — a clean break opens room to run.
A major ceiling 20.3% above — clearing it would confirm fresh momentum.
Key ORGO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ORGO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.48 | Sell | $2.45 | Sell |
| MA 10 | $2.50 | Sell | $2.47 | Sell |
| MA 20 | $2.49 | Sell | $2.48 | Sell |
| MA 50 | $2.47 | Sell | $2.49 | Sell |
| MA 100 | $2.46 | Sell | $2.69 | Sell |
| MA 200 | $3.45 | Sell | $3.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.06 | Neutral |
| Stoch RSI (14) | 0.32 | Buy |
| CCI (20) | -94.77 | Neutral |
| Williams %R (14) | -91.18 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -4.82 | Sell |
| Bollinger %B (20,2) | 0.22 | Neutral |
| Stochastic %K (14) | 8.82 | Buy |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 44.19 | Neutral |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 2.46 | Sell |
| ADX (14) | 9.10 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture shows NEUTRAL sentiment with RSI14 at 50.
SMA50 is $2.47 and SMA200 is $3.51.
Support is at $2.27 and resistance at $2.68; the 30-day range runs from $2.00 to $3.05.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.24 | $2.37 | $3.04 | 0% | Neutral | |
| $2.03 | $2.56 | $3.44 | +8% | Neutral | |
| $1.89 | $2.47 | $3.45 | +4% | Neutral | |
| $2.03 | $2.72 | $3.92 | +15% | Neutral | |
| $2.31 | $3.16 | $4.68 | +33% | Bullish | |
| $2.67 | $3.73 | $5.65 | +57% | Bullish | |
| $2.87 | $4.09 | $6.33 | +73% | Bullish | |
| $2.92 | $4.24 | $6.67 | +79% | Bullish | |
| $3.03 | $4.48 | $7.18 | +89% | Bullish | |
| $2.92 | $4.39 | $7.15 | +85% | Bullish | |
| $4.25 | $6.88 | $11.97 | +190% | Bullish | |
| $7.20 | $13.32 | $25.48 | +462% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.24 | $2.37 | $2.80 | +0.00% |
| September 2026 | $2.02 | $2.39 | $2.92 | +0.87% |
| October 2026 | $2.07 | $2.48 | $3.06 | +3.58% |
| November 2026 | $2.04 | $2.45 | $3.06 | -1.11% |
| December 2026 | $2.00 | $2.42 | $3.04 | -1.22% |
Click any year to see its month-by-month ORGO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Organogenesis Holdings Inc.'s 2026 outlook centres on $2.37, within a $2.24 to $3.04 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ORGO could reach as high as $3.44, with a base case around $2.56 and support toward $2.03 — roughly +8% from $2.37. A consolidation phase looks the most probable path here.
Expect ORGO to range from $1.89 to $3.45 through 2028. The $2.47 average target implies a +4% move from current prices. That is -4% versus the projected 2027 average. Price action looks broadly range-bound.
The ORGO price prediction for 2029 points to an average of $2.72 (low $2.03, high $3.92) — a potential gain of +15% on today's $2.37. A consolidation phase looks the most probable path here.
In 2030, ORGO is projected to trade between $2.31 and $4.68, averaging $3.16 — a potential gain of +33% from today's $2.37. That is up +16% on the projected 2029 average. Momentum favours further upside here.
Organogenesis Holdings Inc.'s 2031 outlook centres on $3.73, within a $2.67 to $5.65 range. That is up +18% on the projected 2030 average. That marks a +57% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ORGO could reach as high as $6.33, with a base case around $4.09 and support toward $2.87 — roughly +73% from $2.37. Momentum favours further upside here.
Expect ORGO to range from $2.92 to $6.67 through 2033. The $4.24 average target implies a +79% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ORGO price prediction for 2034 points to an average of $4.48 (low $3.03, high $7.18) — a potential gain of +89% on today's $2.37. Momentum favours further upside here.
In 2035, ORGO is projected to trade between $2.92 and $7.15, averaging $4.39 — a potential gain of +85% from today's $2.37. That is -2% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Organogenesis Holdings Inc.'s 2040 outlook centres on $6.88, within a $4.25 to $11.97 range. That is up +57% on the projected 2035 average. That marks a +190% change versus current levels. Momentum favours further upside here.
By 2050, ORGO could reach as high as $25.48, with a base case around $13.32 and support toward $7.20 — roughly +462% from $2.37. Buyers look set to stay in control over this stretch.
Investing $1,000 in ORGO today (≈ 421.940928 ORGO) could be worth
$5,618.38
+$4,618.38 (+462%) by 2050 · US Dollar
Based on the average projected ORGO price of $13.32 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ORGOwould be worth at today's price.
$1,000 invested in ORGO on Jul 31, 2025 (≈ 216.450222 ORGO) would be worth
$512.99
-$487.01 (-48.7%) today · 0.51× · US Dollar
Based on a ORGO entry price of $4.62 vs. today's $2.37.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.39 | $991.63 | -0.8% |
| 1 month ago | $2.44 | $971.31 | -2.9% |
| 3 months ago | $2.57 | $922.18 | -7.8% |
| 6 months ago | $4.23 | $560.28 | -44.0% |
| 1 year ago | $4.62 | $512.99 | -48.7% |
| All time (5.0y) ago | $14.81 | $160.03 | -84.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ORGO forecast.
Our base-case forecast reaches $4.70 around 2040.
Implied market cap at $4.70: $604.77M
The multi-year forecast shifts from neutral to bullish beginning in 2030, with 2030 avg $3.29 and ROI 33.3; the forecast continues a bullish trend through 2031 (avg $3.80, ROI 54) and 2032 (avg $4.28, ROI 73.2). Other years show continued gains, including 2033 avg $4.41 (ROI 78.4), 2034 avg $4.54 (ROI 83.9), and 2035 avg $4.52 (ROI 83.2).
The path remains bullish toward 2040 (avg $7.00, ROI 183.3) and 2050 (avg $13.82, ROI 459.4) with a max of $27.20 in 2050 and a min of $7.13. The forecast also notes 2040 max $12.47 and 2030 max $4.95, reflecting a rising price trajectory over time. The outlook carries higher upside but also volatility, as indicated by an annualized volatility of 60.
These are estimates, not guarantees, and reflect projected price levels and sentiment (BULLISH in 2030 onward) rather than certainties.
Tap a question to reveal the answer.
2030 min $2.37, avg $3.29, max $4.95; ROI 33.3; sentiment BULLISH.
Forecasts show bullish sentiment from 2030 onward with rising averages: 2030 avg $3.29 (ROI 33.3), 2040 avg $7.00 (ROI 183.3), 2050 avg $13.82 (ROI 459.4). Earlier years show mixed results and neutral sentiment; these are estimates, not guarantees.
Current price $2.47; Market cap $317.83M; Rank 3296.
The 30-day range is $2.00 to $3.05; RSI14 is 50; SMA50 is $2.47 and SMA200 is $3.51. Support stands at $2.27 and resistance at $2.68.
The 2050 forecast shows max $27.20, with an avg of $13.82 and ROI 459.4; the outlook is bullish, but it remains an estimate rather than a guarantee.
Organogenesis Holdings Inc. Community Discussion
0Share your Organogenesis Holdings Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.